GenomeFit will enable clinical decision making by providing accurate and early diagnostics and drug safety analysis using a revolutionary novel approach for genome analysis to provide diagnoses for patients suffering from genetic diseases and prevent harmful drug effects.
GenomeFit Headquarter Location
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing GenomeFit
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
GenomeFit is included in 5 Expert Collections, including Genomics.
Companies involved in the capture, sequencing, and/or analysis of genetic data
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health & Wellness Assessment
Companies developing or offering products/services that aid in the assessment, screening, diagnosis, or monitoring of one's state of health/wellness. Includes specialized diagnostic centers and physician groups (but excludes diversified facilities and providers).
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Companies that use or incorporate digital technology into their health and wellness product/service offerings.